Cyclerion Therapeutics (CYCN) Total Current Liabilities (2019 - 2025)
Cyclerion Therapeutics (CYCN) has disclosed Total Current Liabilities for 7 consecutive years, with $877000.0 as the latest value for Q3 2025.
- For Q3 2025, Total Current Liabilities rose 25.29% year-over-year to $877000.0; the TTM value through Sep 2025 reached $877000.0, up 25.29%, while the annual FY2024 figure was $725000.0, 65.24% down from the prior year.
- Total Current Liabilities hit $877000.0 in Q3 2025 for Cyclerion Therapeutics, up from $800000.0 in the prior quarter.
- Across five years, Total Current Liabilities topped out at $13.5 million in Q1 2021 and bottomed at $700000.0 in Q3 2024.
- Average Total Current Liabilities over 5 years is $5.6 million, with a median of $4.9 million recorded in 2023.
- Year-over-year, Total Current Liabilities plummeted 80.87% in 2024 and then increased 25.29% in 2025.
- Cyclerion Therapeutics' Total Current Liabilities stood at $11.1 million in 2021, then crashed by 31.2% to $7.6 million in 2022, then plummeted by 72.65% to $2.1 million in 2023, then crashed by 65.24% to $725000.0 in 2024, then rose by 20.97% to $877000.0 in 2025.
- According to Business Quant data, Total Current Liabilities over the past three periods came in at $877000.0, $800000.0, and $1.1 million for Q3 2025, Q2 2025, and Q1 2025 respectively.